Andrey Ignatenko represents international and domestic clients in mergers and acquisitions (M&A), joint ventures, divestments, and corporate restructurings, and also advises on a wide range of general corporate, competition, regulatory, and compliance matters. He counsels clients across multiple industries with a primary focus on pharmaceutical, medical device, and life sciences sectors.
Andrey’s experience also includes advising a number of charities and other nonprofits on corporate and corporate governance matters, including those pertaining to the most complex forms.
Prior to joining Morgan Lewis, Andrey served as a paralegal in the corporate practice of another international law firm. He is fluent in Russian and English.
M&A, Joint Ventures, Divestments and Corporate Restructurings
Regulatory & Compliance
Antitrust & Competition